Report cover image

Global HPV Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 196 Pages
SKU # APRC20552547

Description

Summary

According to APO Research, The global HPV Vaccines market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for HPV Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for HPV Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for HPV Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for HPV Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of HPV Vaccines include Johnson & Johnson, Merck, Pfizer, GlaxoSmithKline, Serum Institute, Sanofi Pasteur, MedImmune, Emergent BioSolutions and CSL, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for HPV Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of HPV Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for HPV Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the HPV Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global HPV Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for HPV Vaccines sales, projected growth trends, production technology, application and end-user industry.

HPV Vaccines Segment by Company

Johnson & Johnson
Merck
Pfizer
GlaxoSmithKline
Serum Institute
Sanofi Pasteur
MedImmune
Emergent BioSolutions
CSL
Astellas Pharma
HPV Vaccines Segment by Type

Adolescents
Adults
HPV Vaccines Segment by Application

Male
Female
HPV Vaccines Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HPV Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of HPV Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HPV Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the HPV Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of HPV Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of HPV Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of HPV Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

196 Pages
1 Market Overview
1.1 Product Definition
1.2 Global HPV Vaccines Market Size, 2020 VS 2024 VS 2031
1.3 Global HPV Vaccines Market Size Estimates and Forecasts (2020-2031)
1.4 Global HPV Vaccines Sales Estimates and Forecasts (2020-2031)
1.5 Global HPV Vaccines Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global HPV Vaccines Market Dynamics
2.1 HPV Vaccines Industry Trends
2.2 HPV Vaccines Industry Drivers
2.3 HPV Vaccines Industry Opportunities and Challenges
2.4 HPV Vaccines Industry Restraints
3 HPV Vaccines Market by Manufacturers
3.1 Global HPV Vaccines Revenue by Manufacturers (2020-2025)
3.2 Global HPV Vaccines Sales by Manufacturers (2020-2025)
3.3 Global HPV Vaccines Average Sales Price by Manufacturers (2020-2025)
3.4 Global HPV Vaccines Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global HPV Vaccines Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global HPV Vaccines Manufacturers, Product Type & Application
3.7 Global HPV Vaccines Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global HPV Vaccines Market CR5 and HHI
3.8.2 Global Top 5 and 10 HPV Vaccines Players Market Share by Revenue in 2024
3.8.3 2024 HPV Vaccines Tier 1, Tier 2, and Tier 3
4 HPV Vaccines Market by Type
4.1 HPV Vaccines Type Introduction
4.1.1 Adolescents
4.1.2 Adults
4.2 Global HPV Vaccines Sales by Type
4.2.1 Global HPV Vaccines Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global HPV Vaccines Sales by Type (2020-2031)
4.2.3 Global HPV Vaccines Sales Market Share by Type (2020-2031)
4.3 Global HPV Vaccines Revenue by Type
4.3.1 Global HPV Vaccines Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global HPV Vaccines Revenue by Type (2020-2031)
4.3.3 Global HPV Vaccines Revenue Market Share by Type (2020-2031)
5 HPV Vaccines Market by Application
5.1 HPV Vaccines Application Introduction
5.1.1 Male
5.1.2 Female
5.2 Global HPV Vaccines Sales by Application
5.2.1 Global HPV Vaccines Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global HPV Vaccines Sales by Application (2020-2031)
5.2.3 Global HPV Vaccines Sales Market Share by Application (2020-2031)
5.3 Global HPV Vaccines Revenue by Application
5.3.1 Global HPV Vaccines Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global HPV Vaccines Revenue by Application (2020-2031)
5.3.3 Global HPV Vaccines Revenue Market Share by Application (2020-2031)
6 Global HPV Vaccines Sales by Region
6.1 Global HPV Vaccines Sales by Region: 2020 VS 2024 VS 2031
6.2 Global HPV Vaccines Sales by Region (2020-2031)
6.2.1 Global HPV Vaccines Sales by Region (2020-2025)
6.2.2 Global HPV Vaccines Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America HPV Vaccines Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America HPV Vaccines Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe HPV Vaccines Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe HPV Vaccines Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific HPV Vaccines Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific HPV Vaccines Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa HPV Vaccines Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa HPV Vaccines Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global HPV Vaccines Revenue by Region
7.1 Global HPV Vaccines Revenue by Region
7.1.1 Global HPV Vaccines Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global HPV Vaccines Revenue by Region (2020-2025)
7.1.3 Global HPV Vaccines Revenue by Region (2026-2031)
7.1.4 Global HPV Vaccines Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America HPV Vaccines Revenue (2020-2031)
7.2.2 North America HPV Vaccines Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe HPV Vaccines Revenue (2020-2031)
7.3.2 Europe HPV Vaccines Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific HPV Vaccines Revenue (2020-2031)
7.4.2 Asia-Pacific HPV Vaccines Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa HPV Vaccines Revenue (2020-2031)
7.5.2 South America, Middle East and Africa HPV Vaccines Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Johnson & Johnson
8.1.1 Johnson & Johnson Comapny Information
8.1.2 Johnson & Johnson Business Overview
8.1.3 Johnson & Johnson HPV Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Johnson & Johnson HPV Vaccines Product Portfolio
8.1.5 Johnson & Johnson Recent Developments
8.2 Merck
8.2.1 Merck Comapny Information
8.2.2 Merck Business Overview
8.2.3 Merck HPV Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Merck HPV Vaccines Product Portfolio
8.2.5 Merck Recent Developments
8.3 Pfizer
8.3.1 Pfizer Comapny Information
8.3.2 Pfizer Business Overview
8.3.3 Pfizer HPV Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Pfizer HPV Vaccines Product Portfolio
8.3.5 Pfizer Recent Developments
8.4 GlaxoSmithKline
8.4.1 GlaxoSmithKline Comapny Information
8.4.2 GlaxoSmithKline Business Overview
8.4.3 GlaxoSmithKline HPV Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 GlaxoSmithKline HPV Vaccines Product Portfolio
8.4.5 GlaxoSmithKline Recent Developments
8.5 Serum Institute
8.5.1 Serum Institute Comapny Information
8.5.2 Serum Institute Business Overview
8.5.3 Serum Institute HPV Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Serum Institute HPV Vaccines Product Portfolio
8.5.5 Serum Institute Recent Developments
8.6 Sanofi Pasteur
8.6.1 Sanofi Pasteur Comapny Information
8.6.2 Sanofi Pasteur Business Overview
8.6.3 Sanofi Pasteur HPV Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Sanofi Pasteur HPV Vaccines Product Portfolio
8.6.5 Sanofi Pasteur Recent Developments
8.7 MedImmune
8.7.1 MedImmune Comapny Information
8.7.2 MedImmune Business Overview
8.7.3 MedImmune HPV Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 MedImmune HPV Vaccines Product Portfolio
8.7.5 MedImmune Recent Developments
8.8 Emergent BioSolutions
8.8.1 Emergent BioSolutions Comapny Information
8.8.2 Emergent BioSolutions Business Overview
8.8.3 Emergent BioSolutions HPV Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Emergent BioSolutions HPV Vaccines Product Portfolio
8.8.5 Emergent BioSolutions Recent Developments
8.9 CSL
8.9.1 CSL Comapny Information
8.9.2 CSL Business Overview
8.9.3 CSL HPV Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 CSL HPV Vaccines Product Portfolio
8.9.5 CSL Recent Developments
8.10 Astellas Pharma
8.10.1 Astellas Pharma Comapny Information
8.10.2 Astellas Pharma Business Overview
8.10.3 Astellas Pharma HPV Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Astellas Pharma HPV Vaccines Product Portfolio
8.10.5 Astellas Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 HPV Vaccines Value Chain Analysis
9.1.1 HPV Vaccines Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 HPV Vaccines Production Mode & Process
9.2 HPV Vaccines Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 HPV Vaccines Distributors
9.2.3 HPV Vaccines Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.